Integrative omics center for accelerating neurobiological understanding of opioid addiction (ican)

Active Project Grant Awarded Last action

Award ID
P50DA054071
Recipient
Awarding agency
Obligated
$26,958,520

Award facts

Assistance listing
93.279 Drug Use and Addiction Research Programs
Completion date 87% complete
Place of performance
Durham, NC 27713, USA

Award details come from USAspending.gov.

Description

Abstract
The overarching goal of the integrative omics center for accelerating neurobiological understanding of opioid addiction (ican) is to identify biologically actionable drivers of opioid addiction (OA). We will (1) conduct large-scale integrated multi-omics studies of OA in humans, (2) integrate rodent-human studies to identify genes and gene networks implicated in OA, and (3) build a publicly available national omics resource for studying OA. Our cohering principle is that by integrating multiple omics across human and animal model data we will discover robust drivers of individual variation that predispose opioid users to addiction. The omics revolution has delivered many discoveries of such individual variation for complex diseases, including for nicotine and alcohol phenotypes, but not for OA. We see five fundamental challenges to rapid progress: (1) limited sample sizes and unaccounted-for phenotypic heterogeneity in genome-wide association studies (gwas) of OA; (2) very limited human brain studies of gene dysregulation by OA; (3) poor translation between human and animal model studies; (4) lack of concurrent integration of multiple omics; and (5) limited practical access to, and poor harmonization of, OA omics data. To overcome these challenges, ican harnesses four projects and two cores: project 1: electronic health record phenotyping and genomics of opioid addiction project 2: gene regulation in the opioid dependent human brain project 3: multi-species approach to opioid addiction project 4: multi-omics gene network identification cores: administrative core and synergy core across these projects and cores, we will (1) conduct the largest gwas to date (n>100,000 cases) leveraging genomic structural equation modeling; (2) examine differential gene regulation across key brain regions (prefrontal cortex, nucleus accumbens, amygdala) in the largest collection of OA informative postmortem brains to date (n=641); (3) integrate rodent and human studies using geneweaver.ORG, polygenic transcriptome risk scores, and variant functionalizing experiments; and (4) apply explainable artificial intelligence, gene network mapping, and multiple lines-of-evidence integration for gene network discovery. Each project is rigorously designed to make novel contributions. However, by integrating the diversity of ican's science through the cross-fertilization and coordinating efforts of the cores, we will leverage the agnostic discovery power of omics and place IT within the context of functional neurobiology to make field-changing breakthroughs and identify actionable targets for development of OA treatments.

Transactions

Action Obligated Date
Amendment $2,071,083
Amendment $0
Amendment $2,175,485
Amendment $2,175,485
Amendment $157,597
Amendment $157,597
Amendment $157,597
Amendment $157,597
Amendment $2,179,245
Amendment $2,179,245
Amendment $2,179,245
Amendment $2,179,245
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $2,223,259
Amendment $2,223,259
Amendment $2,223,259
Amendment $2,259,661
Original award $2,259,661
Show all 22

Subawards

Subrecipient Amount Awarded
University Of California, San Diego PO RTI1000632 Mod 2 Subcontract 9-0218755 $139,435
Icahn School Of Medicine At Mount Sinai 7-312-0218755 Mod 6 PO 67098L $24,574
Icahn School Of Medicine At Mount Sinai 11-312-0218755 Mod 2 PO 70027L $88,101
The Johns Hopkins University 6-312-0218755 Mod 4 PO 67097L $157,986
Ut-Battelle LLC PO RTI1004357 Subcontract 387 Mod 1 $318,622
Ut-Battelle LLC PO RTI1004357 Subcontract 387 $318,622
University Of California, San Diego 2-312-0218755 Mod 4 $61,663
Jackson Laboratory 5-312-0218755 Mod 5 $166,609
Icahn School Of Medicine At Mount Sinai Subcontract 11-312-0218755 Initial Award $86,920
Geisinger Clinic Subcontract 1-312-0218755 Mod 3 $191,391
Whitehead Institute For Biomedical Research Subcontract 8-312-0218755 Mod 4 $145,560
Icahn School Of Medicine At Mount Sinai Subcontract 7-312-0218755 Mod 4 $80,378
Ut-Battelle LLC Subcontract 4-312-0218755 Initial Award $318,622
University Of California, San Diego Subcontract 9-312-0218755 Mod 1 $152,075
Nova Southeastern University, Inc. Subcontract 10-312-0218755 Mod 5 $17,176
University Of California, San Diego Subcontract 2-312-0218755 Mod 3 $59,222
The Johns Hopkins University Subcontract 6-312-0218755 Mod 2 $164,367
Nova Southeastern University, Inc. Subcontract 10-312-0218755 Mod 3 dtd 5-15-24 $57,169.00 and Mod 4 deobligation dtd 6-4-24 ($38688.90) = $18,480.10 $18,480
Icahn School Of Medicine At Mount Sinai Subcontract 7-312-0218755 Mod 3 $219,516
Jackson Laboratory Subcontract 5-312-0218755 Mod 2 $208,933
Whitehead Institute For Biomedical Research Subcontract 8-312-0218755 Mod 3 $102,622
Geisinger Clinic Subcontract 1-312-0218755 Mod 1 $194727 dtd 11-2-2023 and Mod 2 (deoblig) dtd 4-26-2024= $194,727 - (143,809.00)= $50,918 $50,918
Nova Southeastern University, Inc. Subcontract 10-312-0218755 Mod 1 dtd 10-27-2023 $38689 and Mod 2 deoblig (19,204.00) Apr 11, 2024 = $19,485 $19,485
University Of California, San Diego Subcontract 2-312-0218755 Mod 1 $59,035
Icahn School Of Medicine At Mount Sinai Subcontract 7-312-0218755 Mod 2 $80,378
Whitehead Institute For Biomedical Research Subcontract 8-312-0218755 Mod 1 $94,191 and Mod 2 (75,077.29) deobligation = 11,113.71 $11,114
Vanderbilt University Medical Center Subcontract 3-312-0218755 Mod 1 $93,040
The Johns Hopkins University 6-312-0218755 Mod 1 $186,267
Jackson Laboratory Subcontract 5-312-0218755 Mod 1 $166,609
The Johns Hopkins University Subcontract 6-312-0218755 Initial Award $183,963
University Of California, San Diego Subcontract 2-312-0218755 Initial Award $63,014
University Of California, San Diego Subcontract 9-312-0218755 Initial Award $152,075
Vanderbilt University Medical Center Subcontract 3-312-0218755 Initial Award $113,781 and Mod 2(84,628.43) dtd 5-8-2024 = 29,152.57 $29,153
Show all 33

Quick answers

Who received award P50DA054071?

P50DA054071 was awarded to Research Triangle Institute by National Institute on Drug Abuse (National Institutes of Health) on September 15, 2022.

How much is award P50DA054071 worth?

$26,958,520 has been obligated on P50DA054071.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award